Pharmacokinetic and safety of raltegravir in pregnancy


Dear Sirs: The aim of anti-HIV treatment in pregnancy is the suppression of the HIV-1 RNA viral load in the plasma before delivery [1] to prevent mother-to-child transmission of the infection. The achievement of this outcome may be complicated in pregnant women who have been treated with multiple drugs by the lack of active drugs available. Although there… (More)
DOI: 10.1007/s00228-012-1250-5